AbbVie Completes Acquisition of Capstan Therapeutics
Provided By PR Newswire
Last update: Aug 19, 2025
NORTH CHICAGO, Ill., Aug. 19, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) announced today that it has completed its acquisition of Capstan Therapeutics. With the completion of the acquisition, Capstan is now a part of AbbVie.
Read more at prnewswire.com208.36
+0.81 (+0.39%)
Find more stocks in the Stock Screener
ABBV Latest News and Analysis
